Global Genetic Disease Diagnostic Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Genetic Disease Diagnostic Market Overview

• 1.1 Product Overview and Scope of Genetic Disease Diagnostic
• 1.2 Classification of Genetic Disease Diagnostic by Type
  • 1.2.1 Global Genetic Disease Diagnostic Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Genetic Disease Diagnostic Revenue Market Share by Type in 2019
  • 1.2.3 Prenatal diagnosis
  • 1.2.4 Gene therapy
• 1.3 Global Genetic Disease Diagnostic Market by Application
  • 1.3.1 Overview: Global Genetic Disease Diagnostic Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 Inherited disorder testing
  • 1.3.3 Pharmacogenetic testing (PGx)
  • 1.3.4 Human leukocyte antigen (HLA) testing
  • 1.3.5 Oncology testing
• 1.4 Global Genetic Disease Diagnostic Market by Regions
  • 1.4.1 Global Genetic Disease Diagnostic Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Genetic Disease Diagnostic (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Genetic Disease Diagnostic Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Genetic Disease Diagnostic Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Genetic Disease Diagnostic Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Genetic Disease Diagnostic Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Genetic Disease Diagnostic Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 Abbott
  • 2.1.1 Abbott Details
  • 2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 Abbott SWOT Analysis
  • 2.1.4 Abbott Product and Services
  • 2.1.5 Abbott Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 BioRad
  • 2.2.1 BioRad Details
  • 2.2.2 BioRad Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 BioRad SWOT Analysis
  • 2.2.4 BioRad Product and Services
  • 2.2.5 BioRad Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 PerkinElmer
  • 2.3.1 PerkinElmer Details
  • 2.3.2 PerkinElmer Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 PerkinElmer SWOT Analysis
  • 2.3.4 PerkinElmer Product and Services
  • 2.3.5 PerkinElmer Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 Celera Group
  • 2.4.1 Celera Group Details
  • 2.4.2 Celera Group Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 Celera Group SWOT Analysis
  • 2.4.4 Celera Group Product and Services
  • 2.4.5 Celera Group Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 Roche Diagnostics
  • 2.5.1 Roche Diagnostics Details
  • 2.5.2 Roche Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 Roche Diagnostics SWOT Analysis
  • 2.5.4 Roche Diagnostics Product and Services
  • 2.5.5 Roche Diagnostics Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 Elitech Group
  • 2.6.1 Elitech Group Details
  • 2.6.2 Elitech Group Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 Elitech Group SWOT Analysis
  • 2.6.4 Elitech Group Product and Services
  • 2.6.5 Elitech Group Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 Applied Biosystems
  • 2.7.1 Applied Biosystems Details
  • 2.7.2 Applied Biosystems Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 Applied Biosystems SWOT Analysis
  • 2.7.4 Applied Biosystems Product and Services
  • 2.7.5 Applied Biosystems Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 AutoGenomics
  • 2.8.1 AutoGenomics Details
  • 2.8.2 AutoGenomics Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 AutoGenomics SWOT Analysis
  • 2.8.4 AutoGenomics Product and Services
  • 2.8.5 AutoGenomics Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 Quest Diagnostics
  • 2.9.1 Quest Diagnostics Details
  • 2.9.2 Quest Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 Quest Diagnostics SWOT Analysis
  • 2.9.4 Quest Diagnostics Product and Services
  • 2.9.5 Quest Diagnostics Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 Transgenomic
  • 2.10.1 Transgenomic Details
  • 2.10.2 Transgenomic Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 Transgenomic SWOT Analysis
  • 2.10.4 Transgenomic Product and Services
  • 2.10.5 Transgenomic Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Genetic Disease Diagnostic Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Genetic Disease Diagnostic Players Market Share
  • 3.2.2 Top 10 Genetic Disease Diagnostic Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Genetic Disease Diagnostic Revenue and Market Share by Regions
• 4.2 North America Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 4.3 Europe Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 4.5 South America Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)

5 North America Genetic Disease Diagnostic Revenue by Countries

• 5.1 North America Genetic Disease Diagnostic Revenue by Countries (2015-2020)
• 5.2 USA Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 5.3 Canada Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)

6 Europe Genetic Disease Diagnostic Revenue by Countries

• 6.1 Europe Genetic Disease Diagnostic Revenue by Countries (2015-2020)
• 6.2 Germany Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 6.3 UK Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 6.4 France Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 6.5 Russia Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 6.6 Italy Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Genetic Disease Diagnostic Revenue by Countries

• 7.1 Asia-Pacific Genetic Disease Diagnostic Revenue by Countries (2015-2020)
• 7.2 China Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 7.3 Japan Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 7.4 Korea Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 7.5 India Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)

8 South America Genetic Disease Diagnostic Revenue by Countries

• 8.1 South America Genetic Disease Diagnostic Revenue by Countries (2015-2020)
• 8.2 Brazil Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Genetic Disease Diagnostic by Countries

• 9.1 Middle East & Africa Genetic Disease Diagnostic Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 9.3 UAE Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Genetic Disease Diagnostic Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Genetic Disease Diagnostic Revenue and Market Share by Type (2015-2020)
• 10.2 Global Genetic Disease Diagnostic Market Forecast by Type (2019-2024)
• 10.3 Prenatal diagnosis Revenue Growth Rate (2015-2025)
• 10.4 Gene therapy Revenue Growth Rate (2015-2025)

11 Global Genetic Disease Diagnostic Market Segment by Application

• 11.1 Global Genetic Disease Diagnostic Revenue Market Share by Application (2015-2020)
• 11.2 Genetic Disease Diagnostic Market Forecast by Application (2019-2024)
• 11.3 Inherited disorder testing Revenue Growth (2015-2020)
• 11.4 Pharmacogenetic testing (PGx) Revenue Growth (2015-2020)
• 11.5 Human leukocyte antigen (HLA) testing Revenue Growth (2015-2020)
• 11.6 Oncology testing Revenue Growth (2015-2020)

12 Global Genetic Disease Diagnostic Market Size Forecast (2021-2025)

• 12.1 Global Genetic Disease Diagnostic Market Size Forecast (2021-2025)
• 12.2 Global Genetic Disease Diagnostic Market Forecast by Regions (2021-2025)
• 12.3 North America Genetic Disease Diagnostic Revenue Market Forecast (2021-2025)
• 12.4 Europe Genetic Disease Diagnostic Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Genetic Disease Diagnostic Revenue Market Forecast (2021-2025)
• 12.6 South America Genetic Disease Diagnostic Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Genetic Disease Diagnostic Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer